Russian-American lobbyist confirms attending Donald Trump Jr. meeting

Trump Tower Meeting Who Was All There

The outlet said the lobbyist was suspected of having ties to Russian intelligence agencies.

Ahkmetshin told AP that he did not consider the meeting to be "substantive" and had been expecting a "more serious" conversation. Trump Jr. agreed to the meeting because he thought he would be receiving damaging information about Hillary Clinton.

But like a Russian nesting doll, the number of bodies present at Trump Jr.'s meeting somehow keeps multiplying.

Although Trump Jr. has insisted that Vesenikstaya mainly wanted to talk about Russian adoptions, Akhmetshin said she brought a folder with information about an American hedge fund operating in Russia that she believed was funneling money to the Democratic National Committee.

The sticky web of denial and deception surrounding the Trump presidential campaign's contacts with Russian officials and their go-betweens grew larger this week.

Akhmetshin is a dual U.S. The person Futerfas spoke to told the lawyer that he was not working for the Russian government, according to NBC.

"No, that I didn't know until a couple of days ago when I heard about this", Trump said when asked if he knew his eldest son was meeting with Russian attorney Natalia Veselnitskaya.

Earlier this year, Trump Jr. denied in an interview with The New York Times that he had participated in a "setup" meeting with a Russian.

File image of Donald Trump with Donald Jr.

Alan Futerfas, Trump Jr.'s lawyer, told The Hill that the lobbyist mentioned in NBC's report was introduced as a "friend of Veselnitskaya".

"They couldn't wait for the meeting to end", he reportedly said.

Details about the meeting emerged this week as investigators in the House, Senate and Justice Department continue to conduct separate probes concerning last year's presidential election, particularly with respect to whether the Trump campaign colluded in any way with Russian actors. However, accepting campaign opposition research from a foreign government is not a common practice.

Later yesterday, a spokesman for the president's outside legal team contended that participants in the June meeting "misrepresented who they were and who they worked for".

His comment came after a Dow Jones story on Saturday, reported through Fox Business News, that noted Wall Street analysts' forecasts are projecting earnings of near double digits, which would put the second quarter reports at among the best place since the fourth quarter of 2011.

The disclosure form doesn't specify whether Futerfas' payment was meant to be for his representation of Trump's son or someone else.

Related:

Comments

Latest news

Celebrities Who Suffer With Chronic Diseases
Now if that isn’t the epitome of what a BFF is, I don’t know what is! Selena continues to be on chronic medication. There is also a huge list of celebrities past like famous painter vincent Van Gogh who suffered with this disease.

Wimbledon: Garbine Muguruza striving to avoid 'repeat' defeat in final against Williams
The next week, the Razorbacks and. "For the last years, you see a lot of Williams surname", she said . She knows how to play this surface. "Honestly, I look forward to having that problem", Williams says.

Speculation on Donald Trump visit dominates US Women's Open build up
Wie is however playing perhaps the best golf of her career right now with a series of top ten finishes in recent starts. Former No. 1 Stacy Lewis called the prospect of a president coming to the U.S.

Here's what's reportedly in Republicans' new health-care bill
Jason Pye, the vice president for legislative affairs for FreedomWorks, noted that every Republican senator except for Sen. If Republicans don't pass the legislation, Trump said "it would be very bad".

'Astounding' second-chance cancer drug heading for FDA approval
The trial lacked a control group, so investigators can not yet say with certainty how much of an effect the treatment had. The committee decision now gets passed to the FDA which is expected to render a final decision regarding CTL109 by Oct.3.

Other news